It is rumored that Pfizer will strike a US$ 101 bn. deal for acquiring AstraZeneca. AstraZeneca’s market capitalization prior to these rumors (17.04.2014) was US$ 80 bn. If these rumours are true it means that Pfizer is offering 25% premium over the market capitalization of AstraZeneca. Is this a fair price? Normally, the price offered…… Continue reading Pfizer AstraZeneca M&A Rumors – Is US$ 101 bn. the Right Price?
-
Follow
Following
Already have a WordPress.com account? Log in now.
Biostrategy Analytics 